Weronika Duda, PhD, possesses extensive experience in clinical research and academia, having served as a PhD Student at the Nencki Institute of Experimental Biology from October 2011 to October 2017, and as a Junior Researcher at the Instytut Medycyny Doświadczalnej i Klinicznej im. M. Mossakowskiego PAN from December 2010 to September 2011. Prior to these roles, Weronika worked at MTZ Clinical Research Sp. z o.o. from May 2011 to September 2014 in various capacities, including Quality Control Assistant, Clinical Study Coordinator, and Quality Control Specialist. Subsequent industry experience includes a position as a Clinical Trial Specialist at Ryvu Therapeutics from January 2018 to December 2019, followed by roles at AstraZeneca in April 2024 as Global Study Start-up Manager, Global Study Manager, and Global Study Associate Manager. Educational qualifications include a Master of Science in Biochemistry and Molecular Biology from Jagiellonian University and a Doctor of Philosophy in Neurobiology and Behavior from the Nencki Institute of Experimental Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices